首页> 外国专利> METHOD OF INDIVIDUAL USE SYSTEM pulse therapy glucocorticosteroids PATIENTS WITH endocrine ophthalmopathy

METHOD OF INDIVIDUAL USE SYSTEM pulse therapy glucocorticosteroids PATIENTS WITH endocrine ophthalmopathy

机译:个体使用系统脉冲疗法糖皮质激素治疗内分泌性眼病的方法

摘要

Method individual destination system pulse therapy with corticosteroids in patients with endocrine ophthalmopathy, comprising a score of complaints and the objective condition of patients, characterized in that the CAS scale assessed disease activity, the protein content of the heat shock 90 in serum and activity of endocrine ophthalmopathy 3 points, and and a heat shock protein content of 90 less than 38 ng / ml systemic prescribed pulse therapy with glucocorticosteroids.
机译:内分泌性眼病患者用皮质类固醇进行个体目的地系统脉冲治疗的方法,包括投诉量和患者的客观状况,其特征在于CAS量表评估疾病活性,血清热休克蛋白含量90和内分泌活性眼病3分,且热休克蛋白含量低于90 ng / ml小于38 ng / ml全身用糖皮质激素进行脉搏治疗。

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号